Analysis of similarities and differences between coronavirus disease 2019 and severe acute respiratory syndrome

被引:3
作者
Liu, Li-Ting [1 ]
Li, Jie [2 ]
Peng, Gui-Ying [1 ]
Li, Jing [1 ]
Wu, Tong [1 ]
Yu, Zi-Yang [1 ]
Huang, Ming-Ming [1 ]
Zhao, Cui-Yun [1 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Med, Dept Resp, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Resp, Beijing 100029, Peoples R China
关键词
Coronavirus disease; differences; heat poison; severe acute respiratory syndrome; wet poison; PROTEIN; SPIKE;
D O I
10.4103/wjtcm.wjtcm_21_20
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Both coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome (SARS) are epidemic, contagious, sudden, and publicly harmful diseases. The whole-genome nucleotide identity of the pathogens causing the two diseases reached 79.5%. The mechanism and treatment of COVID-19 are still under investigation. Combining the experiences of SARS prevention and treatment in 2003, and the case data and literature of COVID-19, the similarities and differences between the two diseases in terms of causes, susceptible people, characteristics, dialectical mode, and treatment were analyzed. The two diseases are both plagues in terms of Chinese medicine. The cause of SARS was "heat poison," and its pathogenesis was "heat poison, stasis, and qi and yin deficiency." Therefore the treatment regimen was mainly to clear away heat, detoxicate, and expel evil. While the cause of COVID-19 was "wet poison," and its pathogenesis was "wet, poison, heat, stasis, close, syncope, and yang collapse." Hence the basic treatment strategy was to declare lung and remove dampness. Treatment of COVID-19 was clearing away evil qi as soon as possible, with the basic treatment regimen, which was declaring lung, removing dampness, and dispelling the evil. Combined with Traditional Chinese medicine's (TCM's) understanding and experience in SARS prevention and treatment, and Chinese clinical cured cases, we try to provide strategies for people all over the world to understand and respond to COVID-19, through the analysis and comparison. To improve COVID-19 prevention and treatment regimen and give full play to the advantages of TCM.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 31 条
  • [1] Beijing Joint SARS Leadership Group and Information Group, 2003, CHIN J EPIDEMIOL, V24, P1096
  • [2] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
    Chen, Nanshan
    Zhou, Min
    Dong, Xuan
    Qu, Jieming
    Gong, Fengyun
    Han, Yang
    Qiu, Yang
    Wang, Jingli
    Liu, Ying
    Wei, Yuan
    Xia, Jia'an
    Yu, Ting
    Zhang, Xinxin
    Zhang, Li
    [J]. LANCET, 2020, 395 (10223) : 507 - 513
  • [3] Cheng WX, 2020, PROCEEDINGS OF THE 17TH USENIX SYMPOSIUM ON NETWORKED SYSTEMS DESIGN AND IMPLEMENTATION, P19
  • [4] Fan C., 2021, ACE2 EXPRESSION KIDN, DOI [DOI 10.1101/2020.02.12.20022418, 10.1101/2020.02.12.20022418]
  • [5] Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
    Hamming, I
    Timens, W
    Bulthuis, MLC
    Lely, AT
    Navis, GJ
    van Goor, H
    [J]. JOURNAL OF PATHOLOGY, 2004, 203 (02) : 631 - 637
  • [6] Health Committee, DIAGN TREATM PROT 20
  • [7] Huang X, 2020, WORLD J TRADIT CHINE, V2, P134
  • [8] Jin R, 2003, CHIN BLOOD PURIF, V2, P4902
  • [9] Growth, spectral properties, and laser demonstration of Nd:(Lu0.5Gd0.5)2SiO5 crystal
    Li, D. Z.
    Xu, X. D.
    Zhang, J.
    Cong, Z. H.
    Tang, D. Y.
    Ma, J.
    Zhu, H. M.
    Chen, X. Y.
    Wu, F.
    Xia, C. T.
    Xu, J.
    [J]. LASER PHYSICS LETTERS, 2011, 8 (09) : 647 - 652
  • [10] Li L, 2020, CHIN J EPIDEMIOL, V41, P13944